In April, a paper in BMC Ophthalmology identified patterns of eye problems among people who took oral or injectable semaglutide
,
In May 2025, Illumina, Inc., and Ovation.io, Inc., announced the development of the largest commercially available clinical multiomic dataset from 25,000 patients treated with glucagon-like peptide-1 (GLP-1) receptor agonist therapies
Cash-pay readers will usually want MEDVi, insured readers will usually want Ro, and four specific questions settle it
However, it depends on what type of drugs the person gets at this time for injectable semaglutide, it's $197 for the first month and $297 moving forward, per month
Commenting on oral GLP1 therapy more broadly, Fahad Razak of St